N-Benzyl-3-(((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)methyl)-amino)benzamide

ID: ALA4096791

PubChem CID: 137653406

Max Phase: Preclinical

Molecular Formula: C22H19N5O2

Molecular Weight: 385.43

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NCc1ccccc1)c1cccc(NCc2nnc(-c3ccncc3)o2)c1

Standard InChI:  InChI=1S/C22H19N5O2/c28-21(25-14-16-5-2-1-3-6-16)18-7-4-8-19(13-18)24-15-20-26-27-22(29-20)17-9-11-23-12-10-17/h1-13,24H,14-15H2,(H,25,28)

Standard InChI Key:  SVKLMBZNMVZHTI-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   12.9277  -11.2661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2857  -11.7766    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.4020  -12.5903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1636  -12.8904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8137  -12.3789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6900  -11.5631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5706  -12.6876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8123  -13.4742    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.6304  -13.4921    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.9016  -12.7200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2477  -12.2159    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.6983  -12.4890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2867  -13.0606    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.6486  -13.4242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4331  -13.2066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6508  -12.4114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0697  -11.8343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2753  -12.0511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0658  -12.8432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2789  -11.0402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0718  -10.8264    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.6994  -10.4600    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.2809  -10.0323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0738   -9.8144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6538  -10.3964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4460  -10.1832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6558   -9.3883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0714   -8.8069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2814   -9.0233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11  7  1  0
 10 12  1  0
 12 13  1  0
 19 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 13 19  1  0
 17 20  1  0
 20 21  1  0
 20 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4096791

    ---

Associated Targets(Human)

GRK2 Tchem G-protein coupled receptor kinase 2 (1019 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ROCK2 Tclin Rho-associated protein kinase 2 (6206 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKCA Tchem Protein kinase C alpha (5923 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 385.43Molecular Weight (Monoisotopic): 385.1539AlogP: 3.67#Rotatable Bonds: 7
Polar Surface Area: 92.94Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.44CX LogP: 1.83CX LogD: 1.83
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.50Np Likeness Score: -1.84

References

1. Okawa T, Aramaki Y, Yamamoto M, Kobayashi T, Fukumoto S, Toyoda Y, Henta T, Hata A, Ikeda S, Kaneko M, Hoffman ID, Sang BC, Zou H, Kawamoto T..  (2017)  Design, Synthesis, and Evaluation of the Highly Selective and Potent G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure.,  60  (16): [PMID:28699740] [10.1021/acs.jmedchem.7b00443]

Source